HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tc-99m ethylcysteinate dimer SPECT in the differential diagnosis of dementias.

AbstractBACKGROUND:
Dementias produce deficits in perfusion, in part, reflecting decreased metabolic needs. Single photon emission computed tomography (SPECT) studies have reported characteristic anterior-to-posterior perfusion gradients that permit distinction between the various forms of dementia.
AIM:
We undertook this study to evaluate the role of visual analysis of SPECT perfusion patterns for the differential diagnosis of types of degenerative dementia.
MATERIALS AND METHODS:
Tc-99m ethylcysteinate dimer (ECD) was used with a dual-head scanner to generate perfusion images of the brain in 136 patients referred from the dementia clinic. Diagnosis was made by the nuclear physician unaware of clinical diagnosis.
RESULTS:
Sensitivity, specificity, positive predictive value and negative predictive value of perfusion studies for Alzheimer's dementia were 93.42%, 95.12%, 97.26%, and 88.63%, respectively, and for frontotemporal dementia were 96.29%, 98%, 96.29%, and 98.88%, respectively.
CONCLUSIONS:
Tc-99m ECD brain perfusion SPECT is useful in the differential diagnosis of dementia with particular reference to AD as well as FTD.
AuthorsMadhavi Tripathi, Manjari Tripathi, Deepti Vibha, Naveen Gowda, Chandrashekhar Bal, Arun Malhotra
JournalNeurology India (Neurol India) 2010 Nov-Dec Vol. 58 Issue 6 Pg. 857-62 ISSN: 0028-3886 [Print] India
PMID21150049 (Publication Type: Journal Article)
Chemical References
  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • technetium Tc 99m bicisate
  • Cysteine
Topics
  • Aged
  • Cysteine (analogs & derivatives)
  • Dementia (classification, diagnostic imaging)
  • Diagnosis, Differential
  • Female
  • Humans
  • Male
  • Middle Aged
  • Organotechnetium Compounds
  • Predictive Value of Tests
  • Radiopharmaceuticals
  • Sensitivity and Specificity
  • Tomography, Emission-Computed, Single-Photon (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: